European Urology

Article	Citations
Reply to Brett Delahunt, Hemamali Samaratunga, Lars Egevad’s Letter to the Editor re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Eviden	823
Reply to Francesco Montorsi, Nicola Fossati, Carlo A. Bravi, Giorgio Gandaglia, Nazareno Suardi, and Alberto Briganti’s Letter to the Editor re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al	819
Re: European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Cor	471
Acknowledgement to Reviewers	344
Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer	323
Paving the Road to the Future of Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-year Follow-up of BC2001	293
Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell Carcinoma	242
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate Cancer	231
Reply to Binghao Zhao, Ruidong Zhang, and Jiaming Wu’s Letter to the Editor re: Ana Cavillon, Damien Pouessel, Nadine Houédé, et al. Assessing Long-term Treatment Benefits Using Complementary Statisti	213
The Platinum Hall of Fame	205
Ischemia Time Has Little Influence on Renal Function Following Partial Nephrectomy: Is It Time for Urology to Stop the Tick-Tock Dance?	192
Reply to Rui-Cheng Wu, Deng-Xiong Li, and De-Chao Feng’s Letter to the Editor re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Mo	178
Prostate Cancer Screening at its Best: The Swedish Organized Prostate Cancer Testing Program	158
Re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024;8	156
Opening up the Market to New Robotic Platforms: The Best Way To Handle New Options	146
Congress Calendar	138
Editorial Board	137
Re: Sophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via P	133
Behavior of SelectMDx and Prostate-specific Antigen Density in the Challenging Scenario of Prostate Imaging-Reporting and Data System Category 3 Lesions	127
Reply to Fabio Campodonico, Francesca Mattioli, and Carlo Introini’s Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Intravesical Chemohyperthermia Versus Passive C	126
Reply to Xiangyang Yao, Chen Duan, Bo Li, Xiaoliang Wu and Hua Xu’s Letter to the Editor Re: Hilda A. de Barros, Matthias N. van Oosterom, Maarten L. Donswijk, et al. Robot-assisted Prostate-specific	122
Editorial Board	119
Congress Calendar	116
Reply to Alessia Cimadamore, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi’s Letter to the Editor re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both t	115
The Platinum Hall of Fame	111

Reply to Feng Qi, Zicheng Xu, and Qing Zou’s Letter to the Editor re: Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-res	107
Editorial Board	102
Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial	100
Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis	100
Re: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma	94
Honing Stratification and Treatment for High-risk Prostate Cancer	90
Radiopharmaceuticals in Genitourinary Cancers: A Fast-evolving Field with a Bright Perspective	87
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types	85
Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate?	85
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution	84
Contents	83
Congress Calendar	83
Editorial Board	83
Patient and Carer Experiences with Bladder Cancer: Results from a Global Survey in 45 Countries	82
Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer	80
Contents	79
Contents	78
Application of deep learning convolutional neural network in prediction of stone location, skin to stone distance and composition in renal lithiasis: A single center pilot study	76
Reply to Marc Furrer, Niranjan J. Sathianathen, and Nathan Lawrentschuk’s Letter to the Editor re: Pietro Piazza, Luca Sarchi, Stefano Puliatti, Carlo Andrea Bravi, Sophie Knipper, Alexandre Mottrie.	76
Re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association	72
VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prosta	72
Re: Syed A. Hussain, Nuria Porta, Emma Hall, et al. Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial.	70
Re: Percentage Gleason Pattern 4 and PI-RADS Score Predict Upgrading in Biopsy Grade Group 2 Prostate Cancer Patients Without Cribriform Pattern	70
Editorial Board	70
Is Office-based Management of Intermediate-risk Low-grade Non–muscle-invasive Bladder Cancer Ready For Prime Time?	69
Platinum Hall of Fame	69
Re: Unplanned Conversion from Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors	69
Re: Farnoosh Nik-Ahd, Andrew Jarjour, Jane Figueiredo, et al. Prostate-specific Antigen Screening in Transgender Patients. Eur Urol. 2023;83:48–54	68
Re: Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction	68
Putting Precision Medicine in Prostate Cancer into Practice: Are We There Yet?	67
Reply to Borivoj Golijanin, Anthony Mega, and Dragan Golijanin’s Letter to the Editor re: Ivo I. de Vos, Sebastiaan Remmers, Renée Hogenhout, Monique J. Roobol, ERSPC Rotterdam Study Group. Prostate C	66
Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Versus Open Radical Surgery: All Is in the Eye of the Beholder	66
Reply to Kunlin Yang, Xuesong Li, and Liqun Zhou’s Letter to the Editor re: Eduard Roussel, Giovanni Tasso, Riccardo Campi, et al. Surgical Management and Outcomes of Renal Tumors Arising from Horsesh	65
Re: Nivolumab plus Cabozantinib Versus Sunitinib for Advanced Renal-cell Carcinoma	64
Still Unanswered: The Role of Extended Pelvic Lymphadenectomy in Improving Oncological Outcomes in Prostate Cancer	64
Re: Surgical Treatment for Recurrent Bulbar Urethral Stricture: A Randomised Open-label Superiority Trial of Open Urethroplasty Versus Endoscopic Urethrotomy (the OPEN Trial)	63
Re: Pretransplant Solid Organ Malignancy and Organ Transplant Candidacy: A Consensus Expert Opinion Statement	62
Reply to Deepansh Dalela, Isaac Palma-Zamora, and Craig Rogers’ Letter to the Editor re: Fredrick Leidberg, Petter Kollberg, Marie Allerbo, et al. Preventing Parastomal Hernia After Ileal Conduit by t	62
Reply to Yu-Hsiang Lin, Kuo-Jen Lin, and Horng-Heng Juang’s Letter to the Editor re: Massimiliano Creta, Giorgio I. Russo, Naeem Bhojani, et al. Bladder Outlet Obstruction Relief and Symptom Improveme	61
Re: Paolo Dell’Oglio, Hielke M. de Vries, Elio Mazzone, et al. Hybrid Indocyanine Green–99mTc-nanocolloid for Single-photon Emission Computed Tomography and Combined Radio- and Fluorescence-guided Sen	61
Reply to Jason Koehler and Abhinav Sidana’s Letter to the Editor re: Guillaume Ploussard, Patrick Coloby, Thierry Chevallier, et al. Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Ra	61
Magnetic Resonance Imaging–guided Adaptive Radiotherapy for Urological Cancers: What Urologists Should Know	60
The Platinum Hall of Fame	60
Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-inst	60
Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer	58
Everything But the Kitchen Sink: Comprehensive Nodal Irradiation with Androgen Deprivation in OLIGOPELVIS	57
The Platinum Hall of Fame	55
P16 status is an independent predictor of overall survival in metastatic penile cancer in a large contemporary cohort	54
Human Papillomavirus: One Less Worry for Men Too?	54
More Accurate Imaging Is Not Stage Migration: Time To Move from “Hubble” to “Webb” in Hormone-sensitive Prostate Cancer	54

Are We Moving Closer to Accurate Restaging after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer?	53
Geriatric nutritional risk index as a prognostic marker for patients with metastatic castration-resistant prostate cancer receiving docetaxel	52
Fatigue, quality-of-life and metabolic changes in men treated with enzalutamide versus abiraterone plus prednisone for metastatic castration-resistant prostate cancer (HEAT): A randomised trial	52
Severity of COVID-19 infection in prostate cancer patients and effect of ADT on disease presentation	52
Diabetes control in men with type 2 diabetes mellitus and prostate cancer treated with GnRH Agonists: A nationwide, population-based cohort study	51
Balancing efficacy and toxicity of docetaxel in patients with metastatic castration-resistant prostate cancer. Results from a pooled analysis of three prospective randomized trials	51
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups	51
Prospective study of the relationship between clinical outcomes of enzalutamide and serum androgen levels measured by LC-MS/MS in CRPC patients	51
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): An international multicenter study	50
Randomized sham-controlled trial to evaluate the safety and effectiveness of radial waves for erectile dysfunction	49
Comparative analysis of surgical outcomes and cost effectiveness of a novel 3-instrument technique for Robotic Assisted Radical Prostatectomy (RARP) with the standard 5-instrument technique	49
Disease trajectories and outcomes for men with castration resistant prostate cancer by use of nation-wide population-based observational data	49
Results of percutaneous diathermocoagulation of spermatocele	48
Studying the interaction of germ cell tumors with the microenvironment reveals novel factors involved in cisplatin resistance	47
Added value of radiological tumor stage in predicting early oncological outcomes in prostate cancer patients undergoing radical prostatectomy within clinical stage: A stage-by-stage analysis	47
Diagnostic value, oncological outcomes and safety profile of image-guided surgery technologies during robot-assisted lymph node dissection with sentinel node biopsy for prostate cancer	47
Medications mostly associated with ejaculatory disorders: Assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) Pharmacovigilance databases entries	47
PET/CT allows for a reliable assessment of the real nodal burden in clinically node-positive prostate cancer patients candidate for radical prostatectomy: Results from a multi-institutional series	47
Is fast-MRI as accurate as multi-parametric MRI in the detection of clinically significant prostate cancer in biopsy naïve men? A prospective, single centre, non-inferiority randomized trial	47
Beware excluding systematic biopsy in patients undergoing radical prostatectomy: A five year follow up study of biochemical recurrence free survival	46
One day prostate cancer screening and diagnosis using Magnetic Resonance imaging and Digital Prostate Biopsy with fluorescence confocal microscopy	46
The learning curve of prostate MRI/TRUS target fusion biopsy after more than 1000 procedures: Residents’ experience	46
Safety of minimizing intensity of follow-up on active surveillance for clinical stage I testicular germ cell tumors	46
Application of Artificial Intelligence-based classifiers to predict the outcome measures and stone-free status following percutaneous nephrolithotomy for staghorn calculi: Cross-validation of data and	45
Pre-existing detrusor overactivity leads to earlier artificial urinary sphincter failure and need for revision	44
Trans-ethnic genome-wide association study reveals new therapeutic targets for benign prostatic hyperplasia	44
Medium to long term health-related quality of life and treatment-related side-effects in patients treated with a single dose of adjuvant carboplatin for high-risk seminoma – results from a pilot study	43
Evaluation of the effect of umbilical cord derived urethral slings in bilateral pudendal nerves injury-induced urinary incontinence in female rats	43
Prospective analysis of prostate cancer local staging with [18f] psma pet/mri combined with multiparametric mri – a comparison to histopathology in the radical prostatectomy specimen	43
Prostate Mapping: The Madrid protocol (Transperineal prostate biopsies combining Micro-ultrasound and mpMRI fusion biopsy) concordance with robotic radical prostatectomy specimens	43
A new horizon-electromagnetic (EM) needle tip tracking to support mpMRI/US fusion transperineal prostate biopsies under local anaesthetia	43
Using a remote monitoring kit to predict re-admissions for patients discharged following radical cystectomy	42
Lessons learnt from 1010 consecutive robot assisted radical prostatectomies: Safe fellowship training	42
Comparing patient experience between telemedicine and traditional urology visits during the COVID-19 pandemic	42
Visioning - Evaluation of a solely MRI-based, PSA-free prostate cancer screening program	41
Sacral Neuromodulation (SNM) in patients with neurogenic Lower Urinary Tract Dysfunction (nLUTD): A systematic literature review and meta-analysis covering over two decades	41
Are virtual clinics the new normal? A single-institution comparative analysis of outcomes and cost-effectiveness of virtual and face-to-face clinics	41
Finding ideal timing of radiotherapy after radical prostatectomy – the impact on health-related quality of life	41
Regional lymph node metastasis on PSMA-PET correlates with decreased BCR-free and therapy-free survival after radical prostatectomy	40
Comparison of relative survival and cause-specific survival in men with prostate cancer according to age and risk category. Nationwide, population-based study	40
Symptoms suggestive of urinary tract infection rates among intermittent urinary catheter users: Real-world evidence research based on a longitudinal patient database in the UK	40
An algorithm to personalize nerve sparing in men with unilateral high-risk prostate cancer	39
Delayed absent ejaculation in men presenting to the fertility clinic – retrospective cohort study	39
Couples presenting to Infertility Clinics - are they really infertile?	39
Evaluation of the bone-testis axis in patients with azoospermia undergoing surgical sperm retrieval	38
Biochemical recurrence risk adjusted follow-up after radical prostatectomy	38
A new risk calculator to predict changes in IPSS score and risk of AUR / BPH-related surgery in BPH patients with moderate-severe symptoms at risk of disease progression receiving placebo, dutasteride	38
The surgical learning curve for cancer control after robot-assisted radical prostatectomy	37
The Butterfly: A novel minimally invasive transurethral retraction device for BPH	37
Prognostic variability among high-risk prostate cancer patients with pN1 disease according to the primary tumour pathologic features after radical prostatectomy	37
Effect of SARS-CoV-2 infection upon male sexual function: A multi-center analytic study	37
Association between dietary inflammatory index and urinary flow rate: A nationwide study, nhanes 2009-2016	37
The tomato model: The cheapest and craziest way of learning how to puncture a kidney	36
Three-year outcomes after Aquablation compared to TURP: Efficacy and ejaculatory improvements sustained	36
Functional and sexual symptoms improvement after Rezum water vapor therapy for the treatment of LUTS/BPE: 3-year results from the first European observational study	36
10-year follow-up observation of idiopathic detrusor underactivity in the elderly living in community: Treatment and urodynamic changes	36
Hormone treatment–related adverse events (HTR AEs) with darolutamide (DARO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) from the phase 3 ARAMIS study	36
Association of local progression with deterioration of urinary symptoms and occurrence of genitourinary adverse events (AEs) in nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): Post hoc an	36
Indocyanine green guidance during 3D augmented reality robot assisted partial nephrectomy: A step towards the “automatic” overlapping	34
Combined surgical approach for treatment of refractory bladder neck contracture after TURP	34
PSMA-PET for recurrent prostate cancer and guidance of salvage treatments: Is the sooner always the better? (shoot blind or sharpshooting?)	34
Unfavourable outcomes after Holmium Laser Enucleation of the Prostate (HoLEP) are common also in the hands of a very esperienced surgeon – Results from a prospective trial (ExpHo)	33
Impact of early release of apical adenoma during Holmium Laser Enucleation of the Prostate (HoLEP) on early postoperative functional outcome	33
A new technique of widening urethral plate in short bulbar strictures	33
New approach with fat grafting in the management of urethro-genital lichen sclerosus disease	32
Validation of comprehensive pentafecta criteria after open radical cystectomy in bladder cancer patients with long-term oncological follow-up	32
Robot-assisted laparoscopic radical cystectomy with intracorporeal ileal conduit diversion versus open radical cystectomy with ileal conduit in an ERAS setup (BORARC): A double-blinded, randomised fea	32
Back to the future: Is the use of fasciocutaneous penile flap increasing in contemporary years for reconstructing the anterior urethra?	32
Open vs. robot-assisted radical cystectomy with totally intracorporeal urinary diversion: 30-day and 90-day complication rates comparison from a single centre randomised controlled trial	32
ThuLEP vs. open simple prostatectomy for the treatment of prostates larger than 150 cc	32
Survival after neoadjuvant/induction combination immunotherapy versus combination platinum-based chemotherapy for stage III urothelial cancer	32
Adjuvant vs. progression-triggered treatment with gemcitabine after radical cystectomy in platinum-ineligible patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (AUO-AB 22-00): Long-te	31
Is impotence a life-threatening condition?	31
Androgen deprivation therapy and excess mortality during the COVID-19 pandemic	31
KEYNOTE-365 cohort D: Pembrolizumab (pembro) plus abiraterone acetate (abi) and prednisone in chemotherapy (chemo)–naive patients with metastatic castration-resistant prostate cancer (mCRPC)	31
Final results of a prospective, randomized controlled trial assessing the impact of early Dorsal Venous Complex (eDVC) ligation on urinary continence recovery after robot-assisted radical prostatectom	31
Review of iatrogenic ureteric injuries management in a tertiary centre	31
Beta-3 adrenoceptor agonist for the treatment of bladder dysfunction in children: A systematic review and meta-analysis	30
Factors predicting the success of intradetrusor onabotulinum toxin-a treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort	30
Secondary treatment for men with localized prostate cancer: A pooled analysis of PRIAS and ERSPC-Rotterdam datasets within the PIONEER data platform	30

68 Ga-PSMA PET/CT for preoperative lymph nosde staging of high risk prostate cancer	30
Incontinence in boys and girls following succesful primary closure of bladder extrophy: Management with orthotopic ileal neobladder and costruction of anterior intrapelvic neourethra derived from detr	30
Inguinal lymphadenectomy for penile cancer using a fascial sparing technique -outcomes from a single centre	29
Autologous tunica albuginea cells in fibrin scaffold for correction of penile chordee: An experimental study in rabbits	29
The lumbosacral cord repulsive environment does not halt sprouting of bladder afferents and NDO emergence in a NGF concentration-dependent process following spinal cord injury	29
Retzius-sparing robot assisted radical prostatectomy has similar 1-year functional and oncological outcomes as standard robot-assisted radical prostatectomy: Results from a high volume UK centre	29
Effect of pelvic lymph node dissection and its extent on oncological outcomes in intermediate-risk prostate cancer patients: A multicenter study of the Turkish Urooncology Association	29
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP	29
Challenging cases in high-risk prostate cancer patients treated with Retzius-sparing robot-assisted radical prostatectomy	29
Which patients with posterior urethral valves end with chronic renal disease? Follow up of 107 patients	29
Current impact of sexual and urinary symptoms in patients with multiple sclerosis and future perspectives: Results from a prospective, blinded, real-life study	28
Robot-assisted supratrigonal cystectomy and augmentation cystoplasty for neurological bladder in adults: Comparison of extracorporeal vs. intracorporeal diversion	28
Collaborative resilience program to enhance quality of life for post-penectomy patients: Dyadic coping perspective	28
Duration of diabetes mellitus does not have influence on onset of bladder outlet obstruction	28
Our experience in the treatment of penile amputation injury	27
Transrectal ultrasound guided prostate needle biopsy is still a standard of care for prostate cancer diagnosis – A multicentre Australian analysis of infection rates	27
The man in the red coat – Samuel Pozzi (1846-1918): French pioneer of gynecology in the belle époque	27
Intravesical botulinum toxin use in detrusor overactivity: A comparison of long-term outcomes in patients with Multiple Sclerosis and Idiopathic Detrusor Overactivity	27
Risk factors of erectile dysfunction, painful erection and morphological complications after the penile fracture	27
Prognostic nomogram for predicting long-term survival in patients with retroperitoneal liposarcoma	27
Transperineal interstitial laser ablation of the prostate as a minimally-invasive and effective therapeutic option for benign prostatic hyperplasia	27
Prostatic artery embolization compared to trans-urethral resection of the prostate and prostatic urethral lift: A real-world population-based study	27
Safety and side effects after perineal prostate biopsy without antibiotic prophylaxis: Results of a multicenter trial with 30 days follow-up	27
A prospective comparative study of the accuracy and complications of transrectal and transperineal prostate biopsy in the MRI era	27
The effect of duration between sessions on biofeedback treatment in children with dysfunctional voiding	26
Grade and stage misclassification in unfavorable intermediate vs high-risk NCCC prostate cancer candidates for RT plus short vs long-term androgen ADT	26
Anxiety in men on active surveillance: A longitudinal comparison between Italian and Dutch PRIAS patients	26
MRI and MRI-targeted biopsy can detect cribriform cancer of the prostate	26
Development of novel criteria to identify the optimal candidates for active surveillance among men with low-risk prostate cancer and a positive family history. Results from a large, single institution	26
The comparasion of anxiety levels in children who underwent invasive or non-invasive urodynamic studies	26
Evaluation of the efficacies of methylphenidate and biofeedback treatments in giggle incontinence: One-year follow-up study	25
First line avelumab in PD-L1+ve metastatic or locally advanced Urothelial Cancer (aUC) patients unfit for cisplatin: The ARIES trial	25
Impact of non-muscle invasive bladder cancer treatment history on the efficacy of pembrolizumab for patients with metastatic urothelial carcinoma	25
The recovery of renal functions following reversal of unilateral ureteric obstruction in hypertensive subjects	25
Relapses of urogenital tract tuberculosis	24
Inflammatory cytokines promote fibrosis in obstructed ureters	24
Immunomodulatory roles of antimicrobial peptide LL-37 in urinary bladder bacterial infection	24
High concentration oxalate promotes intrarenal calcium oxalate crystals deposition via altering macrophage M1 polarization with change of the IRF-1/miR-301/CSF-1 signals	24
Adjustable artificial urinary sphincter (VICTO): Experience after 104 cases	24
Natural history of Atypical Small Acinar Proliferation (ASAP): A 10-year contemporary series	24
Key steps in the evaluation and treatment planning for successful Prostate Focal Cryotherapy	24
Patients’ preferences, willingness-to-pay and cost of cystoscopy procedures: Results from a large survey-based study in the United Kingdom	23
Development of a novel clinical and radiological risk score to predict septic complications in patients with obstructive uropathy	23
Effects of preoperative immunonutrition on surgical site infections for bladder cancer patients undergoing cystectomy and ileal conduit	23
Real-world cost for first-line treatment for prostate cancer: A comparative cost analysis in the public sector	23
Lactobacillus vaginal suppositories for recurrent cystitis: A phase 2 clinical trial	23
Bacteraemia and bacteria spread into the irrigation fluid during percutaneous nephrolithotomy: A prospective study	23
Is adjuvant amikacin to oral levofloxacine effective for prevention of febrile complications following transrectal prostate biopsy in patients with fluoroquinolone-resistant E.coli in the rectal flora	23
Bioluminescence imaging enables the study of bladder hyperreflexia during urinary tract infections in mice	23
Combination of urinary-exosomal AMACR, ERG and PCA3 surpasses diagnostic power of serum PSA for patients with suspected prostate cancer	23
Active surveillance of small renal masses: Growth rate and oncological outcomes in a prospective series with standardized follow-up protocol	23
Relationship between the clinical profile of women with recurrent urinary tract infections and the prophylactic treatment chosen	22
Contemporary practice patterns in the treatment of Fournier’s gangrene – Implications for planning a Fournier’s gangrene registry	22
Oncological outcomes for patients harboring positive surgical margins following radical cystectomy for muscle-invasive bladder cancer: A retrospective multicentric study of the EAU Young Academic Urol	22
The results of treatment of patients with urolithiasis by Renotinex® in early postoperative period	22
The use of abdominal drain after robot-assisted surgery in urology: Impact on postoperative pain	22
Expression analysis of prostate cancer Hoechst 33342 side populations identifies the differing origins of CRPC	22
The role of 3-D imaging reconstruction in real-life urologic practice: Results from a global survey	22
Evaluation of the evolution of antibiotic prescription in the treatment of Healthcare-Associated Infections (HAIs) in a urology ward after implementing a treatment optimisation programme	22
Troubleshooting and cost-analysis of the senhance surgical robotic system in urology: A community hospital perspective	22
Do women choose urology residency as much as men? Female urology resident representation in Spain in the last decade	21
Health economics - implication of hypofractionated radiotherapy in prostate cancer	21
Development and validation of the metric-based assessment of a robotic dissection task on an avian model	21
Genetic analysis identifies TNFRSF13B involved in prostate cancer progression	21
Hsa_circ_0005221 promotes prostate cancer progression through miR-339-5p/ STAT5a	21
Urology residents simulation training improves clinical outcomes in laparoscopic partial nephrectomy	21
Comprehensive evaluation of MRI accuracy in local staging of penile cancer	21
Checkpoint-related proteins in liquid biopsies and their association with prognostic factors in penile cancer	21
Comparison of perioperative outcomes of single-port da Vinci SP and multiport da Vinci Xi robotic systems in robotic-assisted urologic surgeries	20
Urosepsis in malignant ureteral obstruction or obstructing stones: Is the treatment the same?	20
Peri- and postoperative outcomes of salvage robot-assisted radical prostatectomy in prostate cancer patients: A high-volume center experience	20
Interest of FGSI and LRINEC prognostic scores in the management of Fournier gangrene	19
Impact of the COVID-19 pandemic on urologic care delivery in the United States	19
Our initial experience with running a urological-oncology Multi-Disciplinary Team (MDT) clinic - A new model of care	19
Surgical, functional and patients’ reported outcomes of adult acquired buried penis surgical management	19
The introduction of novel robotic platforms and simulator tasks: Results of a multivariate analysis of factors impacting basic skills acquisition at the HugoTM RAS simulator	19
The natural course and management strategies of renal angiomyolipoma: A comprehensive single-institution series with 20-year experience	19
Randomised Controlled trial comparing safety and efficacy of Urolift to Monopolar TURP	19
Gardnerella vaginalis: Is it an underestimated cause of urinary symptoms in males?	19
Gross hematuria associated with anticoagulation and antiplatelet drugs – relevance of co-medication and pharmacological interactions	19
Phase I/II study of multipeptide cancer vaccine IMA901 in Japanese patients with advanced renal cell cancer with long-term follow up	19
Real-world outcomes of Bladder Sparing Treatments (BSTs) in patients with high-risk non-muscle invasive bladder cancer, who failed or were intolerant to BCG therapy	19
Surgical urinary continence outcomes in female exstrophy-epispadias patients	18
What constitutes complexity rather than difficulty in the surgical reconstruction of pelvic fracture-related urethral injuries?	18
Final validation of a Patient Reported Outcome Measure (PROM) for penile curvature surgery	18
Practice variation in the management of adult hydroceles: A multinational survey	18
Surgical outcomes after treatment of urethral complications following metoidioplasty in transgender men	18
Does every suspicion of prostate cancer need imaging – a risk-based approach to reduce unnecessary mpMRI	18
Flap phalloplasty outcomes in female to male gender affirming surgery: A systematic review	18
Prediction of 90-day mortality after radical cystectomy for bladder cancer in large-scale multicenter collaboration study	17
A study of DNA methylation of bladder cancer markers in urine and bladder tissue of patients with Neurogenic Lower Urinary Tract Dysfunction (NLUTD)	17
Recovery of patient-reported QOL after cystectomy for bladder cancer	17
Propensity matched comparison of radical cystectomy with trimodality therapy for muscle invasive bladder cancer (MIBC): A multi-institutional study	17
Robot assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy: Results from the iROC prospective randomised controlled trial	17
The efficacy and safety of RIRS in the surgical treatment of kidney stones in pediatric patients from a single pediatric urology center	17